PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224488
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224488
Non-alcoholic Steatohepatitis Biomarkers Market with COVID-19 Impact Analysis, By Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Non-alcoholic Steatohepatitis Biomarkers Market size was valued at USD 1,308.1 Million in 2022, expanding at a CAGR of 22.9% from 2023 to 2030.
A severe type of fatty liver disease is non-alcoholic steatohepatitis (NASH). The buildup or deposition of fat in the liver results in NAFLD. NASH is the term used to describe this fat-accumulation syndrome, which results in inflammation and damage. Cirrhosis, a potentially fatal disorder caused by liver scarring, can result from NASH. Fatigue and a little soreness in the upper right abdomen are signs of NASH.
Non-alcoholic Steatohepatitis Biomarkers Market- Market Dynamics
The primary growth-promoting factor is the increasing frequency of chronic liver diseases like NASH and the requirement for their early identification and diagnosis. Although there is no reliable non-invasive approach to diagnose NAFLD, the market for non-alcoholic steatohepatitis biomarkers has enormous development potential. As a result, another significant growth driver is the increasing desire for non-invasive diagnostic methods. Alternative diagnostic procedures, such as liver biopsies, are intrusive and costly, making them unsuitable for patients. Moreover, a favorable environment is being created for the development of liver disease by the rising obesity rate and bad eating habits. As a result, during the projection period, the market demand for NASH biomarkers is anticipated to increase due to the increased prevalence of the chronic liver disease. The continued research in this field is probably going to keep the industry growing.
However, potential growth-restraining factors include the negative effects of Non-Alcoholic Steatohepatitis (NASH) medications and therapies. Furthermore, the market's expansion is being hampered by the FDA's strict rules for biomarker approval. Additionally, the Non-Alcoholic Steatohepatitis Biomarkers Market is being constrained by the absence of sophisticated testing procedures to identify NAFLD.
Non-alcoholic Steatohepatitis Biomarkers Market- Segmentation Analysis:
Based on the type, in 2022, the serum biomarkers market share was the greatest. The segment's dominance is related to serum biomarkers' success and widespread use as a diagnostic tool for NASH. Additionally, it has a competitive advantage when used to distinguish between primary steatosis and NASH. Apolipoprotein B, apolipoprotein A1, leptin, adiponectin, ghrelin, free fatty acids, and tumor necrosis factor-alpha are a few of the novel blood biomarkers that are anticipated to be released and are projected to accelerate market expansion. To address the need for diagnostic tools, major market participants are also concentrating on getting approvals for marketing serum biomarkers-based tests. For instance, Siemens Healthineers received FDA marketing approval for their Enhanced Liver Fibrosis test in 2021.
Based on the end user, the pharma and CRO industry end-use segment held the largest market share during the forecast period. The market is expected to expand as a result of the increased need for non-invasive diagnostic techniques to identify the chronic liver disease and the rising incidence of liver diseases. Additionally, as a result of improved diagnostics, the market for treatments is expanding, which raises the need for pharmaceuticals and ultimately supports the expansion of the entire industry.
Non-alcoholic Steatohepatitis Biomarkers Market- Geographical Insights
North America held the biggest market share in 2022 and is likely to dominate the market during the forecast period, owing to factors such as growing diagnosis rates and the early introduction of innovative products in this region. Biomarker research and development funding is plentiful, which supports pharmaceutical development initiatives and promotes corporate growth. The growing mobility of players and the increased availability of tests in the US market are important factors driving the industry. For instance, in January 2022, the FDA granted a De Novo marketing clearance to ELF Test, a predictive blood test for evaluating disease development in NASH patients. The test is provided through a partnership between Quest Diagnosis and Labcorp.
Key features of the study:
This proposed research study on the Non-alcoholic Steatohepatitis Biomarkers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Non-alcoholic Steatohepatitis Biomarkers market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Non-alcoholic Steatohepatitis Biomarkers market
The impact of COVID-19 on the Non-alcoholic Steatohepatitis Biomarkers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Non-alcoholic Steatohepatitis Biomarkers market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Non-alcoholic Steatohepatitis Biomarkers market, we have also included a competitive landscape and key innovator analysis for the Non-alcoholic Steatohepatitis Biomarkers market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Non-alcoholic Steatohepatitis Biomarkers market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Non-alcoholic Steatohepatitis Biomarkers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET KEY PLAYERS
Siemens Medical Solutions USA, Inc.
Prometheus Laboratories.
GENFIT
BioPredictive
AstraZeneca
Quest Diagnostics
Exalenz Bioscience Ltd
Pfizer, Inc.
Laboratory Corporation of America Holdings.
Bristol-Myers Squibb Company
GLOBAL NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET, BY TYPE
Serum Biomarkers
Hepatic Fibrosis Biomarkers
Apoptosis Biomarkers
Oxidative Stress Biomarkers
Others
GLOBAL NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET, BY END USER
Pharma & CRO Industry
Hospitals
Diagnostic Labs
Academic Research Institutes
GLOBAL NON-ALCOHOLIC STEATOHEPATITIS BIOMARKERS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Non-alcoholic Steatohepatitis Biomarkers Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Non-alcoholic Steatohepatitis Biomarkers Market Snippet by Type
- 2.1.2. Non-alcoholic Steatohepatitis Biomarkers Market Snippet by End User
- 2.1.3. Non-alcoholic Steatohepatitis Biomarkers Market Snippet by Country
- 2.1.4. Non-alcoholic Steatohepatitis Biomarkers Market Snippet by Region
- 2.2. Competitive Insights
3. Non-alcoholic Steatohepatitis Biomarkers Key Market Trends
- 3.1. Non-alcoholic Steatohepatitis Biomarkers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Non-alcoholic Steatohepatitis Biomarkers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Non-alcoholic Steatohepatitis Biomarkers Market Opportunities
- 3.4. Non-alcoholic Steatohepatitis Biomarkers Market Future Trends
4. Non-alcoholic Steatohepatitis Biomarkers Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Non-alcoholic Steatohepatitis Biomarkers Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Non-alcoholic Steatohepatitis Biomarkers Market Landscape
- 6.1. Non-alcoholic Steatohepatitis Biomarkers Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Non-alcoholic Steatohepatitis Biomarkers Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
- 7.1.2. Serum Biomarkers
- 7.1.3. Hepatic Fibrosis Biomarkers
- 7.1.4. Apoptosis Biomarkers
- 7.1.5. Oxidative Stress Biomarkers
- 7.1.6. Others
8. Non-alcoholic Steatohepatitis Biomarkers Market - By End User
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
- 8.1.2. Pharma & CRO Industry
- 8.1.3. Hospitals
- 8.1.4. Diagnostic Labs
- 8.1.5. Academic Research Institutes
9. Non-alcoholic Steatohepatitis Biomarkers Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Non-alcoholic Steatohepatitis Biomarkers Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.2.7. U.S.
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.2.8. Canada
- 9.2.8.1. Overview
- 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.8.4. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Non-alcoholic Steatohepatitis Biomarkers Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Non-alcoholic Steatohepatitis Biomarkers Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Non-alcoholic Steatohepatitis Biomarkers Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Non-alcoholic Steatohepatitis Biomarkers Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Non-alcoholic Steatohepatitis Biomarkers Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Siemens Medical Solutions USA, Inc.
- 10.2.2. Prometheus Laboratories.
- 10.2.3. GENFIT
- 10.2.4. BioPredictive
- 10.2.5. AstraZeneca
- 10.2.6. Quest Diagnostics
- 10.2.7. Exalenz Bioscience Ltd
- 10.2.8. Pfizer, Inc.
- 10.2.9. Laboratory Corporation of America Holdings.
- 10.2.10. Bristol-Myers Squibb Company
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Non-alcoholic Steatohepatitis Biomarkers Market:Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Non-alcoholic Steatohepatitis Biomarkers Market, by Type 2018-2030 (USD Million)
- TABLE Non-alcoholic Steatohepatitis Biomarkers Market: Regional snapshot (2022)
- TABLE Non-alcoholic Steatohepatitis Biomarkers Market: End User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Non-alcoholic Steatohepatitis Biomarkers Market, by End User 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Non-alcoholic Steatohepatitis Biomarkers Market, by Region 2018-2030 (USD Million)
- TABLE North America Non-alcoholic Steatohepatitis Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE North America Non-alcoholic Steatohepatitis Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE North America Non-alcoholic Steatohepatitis Biomarkers Market, by End User, 2018-2030 (USD Million)
- TABLE Europe Non-alcoholic Steatohepatitis Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Non-alcoholic Steatohepatitis Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Europe Non-alcoholic Steatohepatitis Biomarkers Market, by End User, 2018-2030 (USD Million)
- TABLE Asia Pacific Non-alcoholic Steatohepatitis Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Non-alcoholic Steatohepatitis Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Non-alcoholic Steatohepatitis Biomarkers Market, by End User, 2018-2030 (USD Million)
- TABLE Latin America Non-alcoholic Steatohepatitis Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Non-alcoholic Steatohepatitis Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Non-alcoholic Steatohepatitis Biomarkers Market, by End User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Non-alcoholic Steatohepatitis Biomarkers Market, by End User, 2018-2030 (USD Million)
